Medical Marijuana, Inc. Subsidiary HempMeds(R) Names Renowned Cannabis Leader Raul Elizalde as CEO and Matheus Patelli as Managing Director of Brazil Operations
SAN DIEGO, Nov 19, 2020 (GLOBE NEWSWIRE via COMTEX) —
Promotes International Executive Team to Further Capitalize on Growing CBD Market in Latin America
via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds(R) has announced new global and regional leadership promotions.
Raul Elizalde, a prominent international cannabis leader, will become the sole CEO of HempMeds(R), overseeing all US and international operations. He joined the Company in June 2017 and previously served as the President of HempMeds(R) Mexico and Latin American operations. Elizalde was an active medical cannabis advocate prior to joining the Company because of his fight to gain access to cannabidiol (CBD) hemp oil for his daughter Grace. Elizalde’s fight led to the legalization of medical cannabis in Mexico and, since joining the Company, he has significantly grown HempMeds’ presence and sales throughout Latin America, especially in Mexico. In Nov. 2017,…